West Pharmaceutical Services
West Pharmaceutical Services Quality Analysis
West Pharmaceutical Services (WST) is a good quality business scoring 73/100, with particular strength in earnings predictability and financial strength. The business has solid fundamentals but falls short of elite quality on some measures.
West Pharmaceutical Services a-t-elle un rempart concurrentiel (moat) solide ?
West Pharmaceutical Services operates with a narrow competitive moat. While the business generates acceptable returns, it lacks the consistent margin superiority or return on capital that would indicate strong pricing power or durable competitive advantages. Competition could erode profitability over time.
West Pharmaceutical Services a-t-elle un pricing power dans son secteur ?
West Pharmaceutical Services has limited pricing power. The company operates with margins that are average for its industry, and revenue growth has come with some margin pressure. This suggests the business competes partially on price rather than on differentiated value.
Quelle est la prévisibilité de l'activité de West Pharmaceutical Services ?
West Pharmaceutical Services is a highly predictable business with remarkably consistent financial performance. Revenue growth has been steady with low volatility, and the company has delivered positive free cash flow in 8 of the last 8 years. This consistency makes future earnings relatively easy to forecast with confidence.
West Pharmaceutical Services est-elle financièrement solide ?
West Pharmaceutical Services has an exceptionally strong balance sheet with a conservative debt-to-equity ratio of 0.07x and interest coverage of 39.0x. The company could comfortably weather a severe economic downturn. This financial fortress provides strategic flexibility and reduces risk for long-term shareholders.
Quelle est l'efficacité de la stratégie d'allocation de capital de West Pharmaceutical Services ?
West Pharmaceutical Services demonstrates excellent capital allocation, averaging 25.8% return on capital while reducing shares outstanding through buybacks. Management deploys capital at rates well above the cost of capital, creating significant value for shareholders.
The allocation between reinvestment, buybacks, and dividends appears disciplined and shareholder-friendly.
West Pharmaceutical Services a-t-elle une direction de haute qualité ?
West Pharmaceutical Services's management team demonstrates strong execution, with stock-based compensation kept to just 0.9% of revenue. Consistent high returns on capital and stable operating margins indicate a team focused on operational excellence and long-term value creation rather than short-term metrics.
West Pharmaceutical Services est-elle une entreprise de qualité ?
West Pharmaceutical Services est une entreprise de qualité a good avec un score de qualité de 73/100
Predicted probability of operating margin improvement over the next 12 months
- Capital allocation is the strongest dimension at 97/100.
- Pricing power is the weakest area at 48/100 and needs attention.
- Average gross margin of 37.9% over 5 years.
- Positive free cash flow in 8 of the last 8 years.
- Debt-to-equity ratio of 0.07x.
Quelle est le prix juste de l'action West Pharmaceutical Services ?
West Pharmaceutical Services est-elle un bon investissement à $240 ?
L'analyse suivante est fournie à des fins d'information et d'éducation uniquement. Elle ne constitue pas un conseil financier, un conseil en investissement ou une recommandation d'achat ou de vente de titres. Les opinions exprimées sont basées sur des informations publiques et des données historiques. Beanvest et ses contributeurs peuvent détenir des positions dans les titres mentionnés. Les investisseurs doivent effectuer leur propre diligence raisonnable ou consulter un conseiller financier agréé avant de prendre toute décision d'investissement.